Eastwood Bio-Medical Canada Insider Trading

Eastwood Bio-Medical Canada Inc. is a subsidiary of Eastwood Bio-Medical Research Inc. that markets, develops research for, and distributes natural health products in Canada, the United States, and Asia. The company’s products are sold under the Eleotin brand and focus primarily on natural remedies for metabolic disorders, including blood glucose disorders, hypertension, and obesity. Its product lineup includes several formulations targeting a range of health concerns: Eleotin A 700 addresses spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 serves as a laxative; Eleotin Cal20 and Eleotin V3D support bone and teeth health; Eleotin G2000 targets cardiovascular health; Eleotin H55 functions as a sedative and tension reliever; and Eleotin Zn330 supports tissue formation and metabolism. The company also offers Eleotin Bentley to promote healthy glucose levels and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada holds a joint research agreement with BioNexus Inc. to develop a platform that uses artificial intelligence applied to herbal ingredient prescription data to identify candidates for natural drugs and functional food products. The company is based in Richmond, Canada and was incorporated in 2010.